The Analysis of Royalty Pharma Sub-Manager, LLC's Holdings & P&L

Currently, Royalty Pharma Sub-Manager, LLC holds 4 types of securities in its portfolio with a total value $172.8M. In the most recent quarter, they have increased their positions in BCAX (+1.1M shares, valued at $22.0M).

1M P&L

+10.0M+5.73%

3M P&L

+31.4M+20.60%

HY P&L

+55.7M+43.40%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Biotechnology111.3M

75.2%

2Drug Manufacturers - Specialty & Generic36.6M

24.8%

Top Industries by Stock Count

1Biotechnology2 stocks

66.7%

2Drug Manufacturers - Specialty & Generic1 stocks

33.3%

Sponsored

Stock Holdings

TickerCompany NameSharesShares △%Event DateReport DateHistory

CYTK CYTOKINETICS, INC980.4K shares0.00%2026-03-312026-05-14

BCAX ZENAS BIOPHARMA, INC.2.4M shares89.06%2026-03-312026-05-14

BCRX BIOCRYST PHARMACEUTICALS INC3.8M shares0.00%2026-03-312026-05-14

BIOHAVEN LTD BIOHAVEN LTD2.9M shares0.00%2026-03-312026-05-14

CYTK

CYTOKINETICS, INC

0.00%

Shares980.4K

Event2026-03-31

Filed2026-05-14

BCAX

ZENAS BIOPHARMA, INC.

89.06%

Shares2.4M

Event2026-03-31

Filed2026-05-14

BCRX

BIOCRYST PHARMACEUTICALS INC

0.00%

Shares3.8M

Event2026-03-31

Filed2026-05-14

BIOHAVEN LTD

0.00%

Shares2.9M

Event2026-03-31

Filed2026-05-14

Call Option Holdings

No call option holdings data available

Put Option Holdings

No put option holdings data available